Xiaoquan Huang | Health and Medicine Advances | Research Excellence Award

Published on by New Scientists

Dr. Xiaoquan Huang | Health and Medicine Advances | Research Excellence Award

Associate Researcher | Zhongshan Hospital, Fudan University | China

Dr. Xiaoquan Huang is an accomplished clinical researcher whose work centers on gastroenterology, hepatology, metabolic liver disease, portal hypertension, gastrointestinal bleeding, and global disease epidemiology. With 848 Scopus citations, 79 publications, and an h-index of 13, his research demonstrates sustained impact across Health Sciences, Pharmacology & Toxicology, Cardiology, Endocrinology, Geriatrics, Neurology, Psychiatry, Pulmonary Medicine, Radiology, and related clinical domains. His research portfolio features high-quality journal publications in Chinese Medical Journal, Journal of Gastroenterology and Hepatology, Thrombosis and Haemostasis, Endoscopy, Liver International, Therapeutic Advances in Chronic Disease, and Journal of Translational Medicine. His works span clinical investigations, systematic reviews, global burden analyses, and translational studies addressing cirrhosis-related complications, portal vein thrombosis, metabolic-associated fatty liver disease, and early-onset colorectal cancer. Dr. Xiaoquan Huang has also served as a corresponding author on several influential global epidemiology studies focused on colorectal cancer and fatty liver disease burden.  Dr. Xiaoquan Huang’s scholarly contributions include research on variceal bleeding management, endoscopic innovations, thrombosis prediction markers, myeloproliferative neoplasm-associated portal hypertension, and gastrointestinal microbiome trends. His findings have advanced evidence-based approaches for cirrhotic complications, individualized treatment strategies, endoscopic therapy optimization, and risk stratification in liver disease. He has contributed to meta-analyses and systematic reviews, including work on transoral incisionless fundoplication (TIF) for GERD and therapeutic evaluations in portal hypertension, expanding global clinical understanding and practice guidelines. His research awards include multiple Young Investigator accolades from APDW, EASL, and JGHF, reflecting international recognition for innovation and research excellence. Dr. Xiaoquan Huang’s academic leadership includes reviewer service, conference presentations, and contributions to collaborative global research projects. His ongoing work continues to shape diagnostic, therapeutic, and epidemiological frameworks in hepatology and gastroenterology, establishing him as a significant contributor to clinical research and patient-centered innovations.

Profiles: Scopus | ORCID | ResearchGate | Sci Profiles

Featured Publications

1. Huang, X., Zou, D., Wang, H., Chen, W., Zhang, L., Li, F., Ma, L., Zhang, C., Chen, Y., & Chen, S. (2024). Gastric variceal obstruction improves the efficacy of endoscopic management of esophageal variceal bleeding in GOV type I. Endoscopy International Open, 12(8), E940–E946.

2. Wang, Y., Huang, X. (Corresponding author), Cheryala, M., Aloysius, M., Zheng, B., Yang, K., Chen, B., Fang, Q., Chowdary, S. B., Abougergi, M. S., & Chen, S. (2023). Global increase of colorectal cancer in young adults over the last 30 years: An analysis of the Global Burden of Disease Study 2019. Journal of Gastroenterology and Hepatology, 38(9), 1552–1558.

3. Jiang, S., Ai, Y., Fan, X., Huang, X. (Corresponding author), Wu, L., Ni, L., Li, F., & Chen, S. (2023). Increased factor VIII activity is predictive of the occurrence of portal vein thrombosis in cirrhosis. Thrombosis and Haemostasis, 123(7), 714–722.

4. Huang, X., Zhang, M., Ai, Y., Jiang, S., Xiao, M., Wang, L., Jian, Y., Zhuge, Y., Zhang, C., & Chen, S. (2022). Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding. Therapeutic Advances in Chronic Disease, 13, Article 20406223221125691.

5. Huang, X., Abougergi, M. S., Sun, C., Murphy, D., Sondhi, V., Chen, B., Zheng, X., Chen, S., & Wang, Y. (2023). Incidence and outcomes of thromboembolic and bleeding events in patients with liver cirrhosis in the USA. Liver International, 43(2), 434–441.

Xiaomei Lyu | Genetic Engineering and Biotechnology | Best Researcher Award

Published on by New Scientists

Prof. Xiaomei Lyu | Genetic Engineering and Biotechnology | Best Researcher Award

Professor | Jiangnan University | China

Prof. Xiaomei Lyu is a leading researcher in synthetic biology-driven food science, microbial engineering, and biotechnology. Her work focuses on designing programmable microbial systems, metabolic pathway engineering, and CRISPR-based genetic regulation for applications in food functionality, metabolic health, and biomanufacturing. Her research contributions span high-impact areas such as microbial biosensing, host–microbe interaction engineering, and sustainable biosynthesis of value-added compounds. Prof. Xiaomei Lyu has contributed significantly to the development of engineered microbial genetic circuits targeting biomedical and functional-food applications. Her notable advancements include CRISPR-regulated biosensing systems and controllable nanocarriers enabling active delivery of gene-editing components (Small, 2021). She has also pioneered strategies for modularizing and optimizing metabolic pathways in microbial chassis to enhance production efficiency of nutraceutical compounds, as demonstrated in her work on delta-tocotrienol biosynthesis (Journal of Agricultural and Food Chemistry, 2023). Her research on Rhizobium-derived beta-glucan has opened new avenues in microbiota-modulated metabolic regulation. These works revealed mechanisms by which microbial polysaccharides influence triglyceride metabolism, intestinal fat absorption, and gut–host crosstalk, producing valuable implications for obesity and metabolic disorder interventions (Food & Function, 2022; 2024). Additionally, Prof. Xiaomei Lyu has made recognized contributions to enzymatic and chemo-catalytic processes relevant to food biotechnology, including lactulose production and salidroside biosynthesis, helping advance industrial and functional food innovation. Her publication record includes influential papers in Nature Communications, Small, Food & Function, Biotechnology Advances, Phytochemical Reviews, and Journal of Agricultural and Food Chemistry, supported by strong citation performance (Scopus: 1,515 citations, 59 documents, h-index 22). Her scholarly impact extends to R&D in microbial engineering, biochemical pathways, food-derived therapeutics, and microbiome-based metabolic interventions. Prof. Xiaomei Lyu’s research achievements establish her as a prominent contributor to next-generation microbial biotechnology, functional food science, and precision metabolic modulation.

Profiles: Scopus | ResearchGate | Sci Profiles

Featured Publications

1. Gu, B., Zhang, W.-D., Feng, J.-D., Zhao, W., Gu, Z.-G., & Lyu, X. (2025). Upcycling CO₂ into single cell protein via an integrated electrocatalytic–biosynthetic system. ACS Sustainable Chemistry & Engineering. https://doi.org/10.1021/acssuschemeng.5c06506

2. Wang, L., Zeng, Q., Gu, J., Wang, M., Yang, R., & Lyu, X. (2025). High conversion of value-added lactulose from lactose-rich dairy waste by in vivo cascade cell factory. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c03933

3. Zeng, Q., & Lyu, X. (2025). Identification of a novel cellobiose 2-epimerase from Acidobacteriota bacterium and its application for in-situ milk catalysis. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2025.1575725

4. Liu, H., Zeng, Q., Zhu, C., Xu, C., Yang, R., & Lyu, X. (2025). High-throughput screening and directed evolution of β-1,3-N-acetylglucosaminyltransferase for enhanced LNnT production in engineered Saccharomyces cerevisiae. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c01311

5. Liu, H., Liu, Y., Hu, H., Zhang, S., Lyu, X., & Yang, R. (2024). De novo production of LNnT by metabolic engineering of Saccharomyces cerevisiae as cell factory. Food Science and Human Wellness. https://doi.org/10.26599/fshw.2024.9250342

Priyanka Garg | Health and Medicine | Best Researcher Award

Published on by New Scientists

Ms. Priyanka Garg | Health and Medicine | Best Researcher Award

Assistant Professor, Lovely Professional University, India

Ms. Priyanka Garg is currently serving as an Assistant Professor at the School of Pharmaceutical Sciences, Lovely Professional University (LPU), Punjab, India, where she contributes actively to academic instruction, clinical research, and student mentorship. She holds an M.Pharm in Pharmacy Practice (2022) and a B.Pharm (2020), both from Lovely Professional University, with specialization in pharmacotherapy, pharmacovigilance, and patient-centered care. Her primary research interests encompass pharmacogenomics, clinical pharmacology, women’s health, chronic disease management, and the role of gut microbiota in metabolic disorders, with emerging work focusing on personalized medicine for PCOS and Ehlers-Danlos Syndrome. Professionally, she has served at LPU since January 2023 and previously trained at Shiva Biogenetic Pharmaceuticals Pvt. Ltd. and Doaba Hospital Pvt. Ltd., where she gained practical expertise in manufacturing, IPQC, patient monitoring, and clinical data analysis. Her key contributions include two granted copyrights—“Laboratory and Clinical Result for Polycystic Ovary Syndrome” (2024) and “Clinical Findings for Ehlers-Danlos Syndrome” (2025)—and several impactful presentations at national and international conferences such as SHE-SCIENCE 2025 and the International Conference of Pharmacy series. She has published indexed research in reputed journals including Obesity Medicine and Human Gene. Her scholarly influence is reflected through her author metrics: 3 documents, 25 citations and an h-index of 2. Among her awards and honors, she was recognized for her publication on Type 2 Diabetes Mellitus and Quality of Life (2022) and received accolades for her leadership roles as Faculty Coordinator and Organizing Committee Member for major scientific events at LPU. Additionally, she serves as a Reviewer for the Population Medicine Journal and engages in academic outreach, environmental awareness, and student development programs. Through her interdisciplinary research and commitment to education, Ms. Priyanka Garg aims to advance pharmacogenomics-based therapeutic strategies and promote evidence-driven healthcare innovation that bridges scientific discovery with societal impact.

Profile: Scopus | ORCID | ResearchGate

Featured Publications

1. Garg, P., & Yanadaiah, P. (2025). Assessment of quality of life among type 2 diabetes mellitus and hypertensive patients in Punjab region: A WHOQoL-BREF based hospital study. Obesity Medicine, 58, 100651.

2. Garg, P., Jallepalli, V. R., & Verma, S. (2024). Unravelling the CXCL12/CXCR4 axis in breast cancer: Insights into metastasis, microenvironment interactions, and therapeutic opportunities. Human Gene, 40, 201272.

3. Garg, P., & Duggal, N. (2022). Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed–A review. Obesity Medicine, 35, 100459.